TY  - JOUR
AU  - Iorio, A
AU  - Barbara, A M
AU  - Makris, M
AU  - Fischer, K
AU  - Castaman, G
AU  - Catarino, C
AU  - Gilman, E
AU  - Kavakli, K
AU  - Lambert, T
AU  - Lassila, R
AU  - Lissitchkov, T
AU  - Mauser-Bunschoten, E
AU  - Mingot-Castellano, M E
AU  - Ozdemir, N
AU  - Pabinger, I
AU  - Parra, R
AU  - Pasi, J
AU  - Peerlinck, K
AU  - Rauch, A
AU  - Roussel-Robert, V
AU  - Serban, M
AU  - Tagliaferri, A
AU  - Windyga, J
AU  - Zanon, E
PY  - 2017
DO  - 10.1111/hae.13167
UR  - http://hdl.handle.net/10668/10869
T2  - Haemophilia : the official journal of the World Federation of Hemophilia
AB  - Development of inhibitors is the most serious complication in haemophilia A treatment. The assessment of risk for inhibitor formation in new or modified factor concentrates is traditionally performed in previously treated patients (PTPs). However,...
LA  - en
KW  - factor VIII inhibitors
KW  - haemophilia A
KW  - previously treated patients
KW  - Adult
KW  - Hemophilia A
KW  - Humans
KW  - Middle Aged
KW  - Natural History
KW  - Risk Factors
TI  - Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series.
TY  - research article
VL  - 23
ER  -